Presenting Fate Therapeutics Today we are presenting Fate Therapeutics (FATE); a clinical-stage company developing programmed cellular immunotherapies …

Vertex and Regeneron Will Survive the Coronavirus Market Vertex We picked Vertex (VRTX) on March 18, …

Exelixis, Takeda and Japanese RCC Patients Today we learned from Exelixis (EXEL) that Takeda Pharmaceutical Company …

Coronavirus: The Possible Treatments While Moderna’s (MRNA) vaccine is being tested and its stock price continued …

COVID-19, The Market Rebounding and the Biotech Firms That Did and Didn't Rally The Market Rebounding …

Compugen Soaring in an Extremely Down Market The stocks' prices tumbled today except for very few …

Treating and Preventing COVID-19 Treating COVID-19, Gilead Sciences With regard to treating patients with COVID-19 we …

Gilead Sciences to Acquire Forty Seven Gilead Sciences (GILD) and Forty Seven (FTSV) announced today that the companies …

COVID-19 and the Stock Market The coronavirus that causes COVID-19 is the topic that swallowed all other …

Gilead and Moderna Stocks Will Outperform Today As stated in Prohost Letter #439 Gilead (GILD) investigational …